DUALAMS Overview
- Founded
- 2012

- Status
- Private
- Employees
- 2

- Latest Deal Type
- Accelerator/Inc
- Latest Deal Amount
- $30K

- Investors
- 1
DUALAMS General Information
Description
Developer of a medical instrument designed to ease patient pre-and post-operative experiences. The company's medical instrument offers to inject nebulized lidocaine which eases the process and eliminates reflex gagging, coughing, aspiration, bucking, and laryngospasm, enabling clinicians to perform the examinations efficiently.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
- 7139 Azalea
- Dallas, TX 75230
- United States
DUALAMS Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 31-Aug-2015 | $30K | 0000 | Completed | Generating Revenue |
DUALAMS Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
John Houston | Founder & Chief Executive Officer |
DUALAMS Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialDUALAMS Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Health Wildcatters | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |